Cargando…
P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431155/ http://dx.doi.org/10.1097/01.HS9.0000971368.08106.5c |
| _version_ | 1785091134023794688 |
|---|---|
| author | Jurczak, Wojciech Ghesquieres, Herve Karimi, Yasmin Cheah, Chan Roost Clausen, Michael Cunningham, David Rok Do, Young Lewis, David Gasiorowski, Robin Min Kim, Tae Poel, Marjolein Van Der Limei Poon, Michelle Feldman, Tatyana Linton, Kim Sureda, Anna Hutchings, Martin Kanoun, Salim Vercellino, Laetitia Cota Stirner, Mariana Mcgoldrick, Stephanie Liu, Yan Sacchi, Mariana Lugtenburg, Pieternella Thieblemont, Catherine |
| author_facet | Jurczak, Wojciech Ghesquieres, Herve Karimi, Yasmin Cheah, Chan Roost Clausen, Michael Cunningham, David Rok Do, Young Lewis, David Gasiorowski, Robin Min Kim, Tae Poel, Marjolein Van Der Limei Poon, Michelle Feldman, Tatyana Linton, Kim Sureda, Anna Hutchings, Martin Kanoun, Salim Vercellino, Laetitia Cota Stirner, Mariana Mcgoldrick, Stephanie Liu, Yan Sacchi, Mariana Lugtenburg, Pieternella Thieblemont, Catherine |
| author_sort | Jurczak, Wojciech |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431155 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311552023-08-17 P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA Jurczak, Wojciech Ghesquieres, Herve Karimi, Yasmin Cheah, Chan Roost Clausen, Michael Cunningham, David Rok Do, Young Lewis, David Gasiorowski, Robin Min Kim, Tae Poel, Marjolein Van Der Limei Poon, Michelle Feldman, Tatyana Linton, Kim Sureda, Anna Hutchings, Martin Kanoun, Salim Vercellino, Laetitia Cota Stirner, Mariana Mcgoldrick, Stephanie Liu, Yan Sacchi, Mariana Lugtenburg, Pieternella Thieblemont, Catherine Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431155/ http://dx.doi.org/10.1097/01.HS9.0000971368.08106.5c Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Jurczak, Wojciech Ghesquieres, Herve Karimi, Yasmin Cheah, Chan Roost Clausen, Michael Cunningham, David Rok Do, Young Lewis, David Gasiorowski, Robin Min Kim, Tae Poel, Marjolein Van Der Limei Poon, Michelle Feldman, Tatyana Linton, Kim Sureda, Anna Hutchings, Martin Kanoun, Salim Vercellino, Laetitia Cota Stirner, Mariana Mcgoldrick, Stephanie Liu, Yan Sacchi, Mariana Lugtenburg, Pieternella Thieblemont, Catherine P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title | P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_full | P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_fullStr | P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_full_unstemmed | P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_short | P1118: LONGER FOLLOW-UP FROM THE PIVOTAL EPCORE NHL-1 TRIAL REAFFIRMS SUBCUTANEOUS EPCORITAMAB INDUCES DEEP, DURABLE COMPLETE REMISSIONS IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA |
| title_sort | p1118: longer follow-up from the pivotal epcore nhl-1 trial reaffirms subcutaneous epcoritamab induces deep, durable complete remissions in patients with relapsed/refractory large b-cell lymphoma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431155/ http://dx.doi.org/10.1097/01.HS9.0000971368.08106.5c |
| work_keys_str_mv | AT jurczakwojciech p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT ghesquieresherve p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT karimiyasmin p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT cheahchan p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT roostclausenmichael p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT cunninghamdavid p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT rokdoyoung p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT lewisdavid p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT gasiorowskirobin p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT minkimtae p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT poelmarjoleinvander p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT limeipoonmichelle p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT feldmantatyana p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT lintonkim p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT suredaanna p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT hutchingsmartin p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT kanounsalim p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT vercellinolaetitia p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT cotastirnermariana p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT mcgoldrickstephanie p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT liuyan p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT sacchimariana p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT lugtenburgpieternella p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma AT thieblemontcatherine p1118longerfollowupfromthepivotalepcorenhl1trialreaffirmssubcutaneousepcoritamabinducesdeepdurablecompleteremissionsinpatientswithrelapsedrefractorylargebcelllymphoma |